PERSPECTA

News from every angle

Back to headlines

Immunic Secures $400 Million Funding for Commercial Development

Immunic has successfully secured $400 million in funding to support the commercial-stage development of its projects. This capital injection will aid in advancing its pipeline.

16 Feb, 10:48 — 16 Feb, 10:48
PostShare

Sources

Showing 1 of 1 sources